What is the current annual cash from financing of ABBV?

As of today, ABBV annual cash from financing is -$12.72B

What is 1-year change in ABBV annual cash from financing?

ABBV annual cash from financing is down -144.18% year-over-year

What is 3-year change in ABBV annual cash from financing?

ABBV annual cash from financing is up +48.70% over the past 3 years

How far is ABBV annual cash from financing from its all-time high?

ABBV annual cash from financing is currently -168.01% below its historical high of $18.71B set on December 31, 2019

How does ABBV annual cash from financing rank versus sector peers?

ABBV annual cash from financing is higher than 0.18% of companies in Healthcare sector

When is ABBV next annual earnings release?

The next annual earnings release for ABBV is on February 3, 2027

What is the current quarterly cash from financing of ABBV?

As of today, ABBV quarterly cash from financing is $6.82B

What is ABBV quarterly cash from financing most recent change?

ABBV quarterly cash from financing was up +234.94% on September 30, 2026

What is 1-year change in ABBV quarterly cash from financing?

ABBV quarterly cash from financing is up +248.58% year-over-year

How far is ABBV quarterly cash from financing from its all-time high?

ABBV quarterly cash from financing is currently -74.36% below its historical high of $26.60B set on December 31, 2019

How does ABBV quarterly cash from financing rank versus sector peers?

ABBV quarterly cash from financing is higher than 100.00% of companies in Healthcare sector

When is ABBV next earnings release?

The next earnings release for ABBV is on February 3, 2027

What is the current TTM cash from financing of ABBV?

As of today, ABBV TTM cash from financing is -$1.48B

What is ABBV TTM cash from financing most recent change?

ABBV TTM cash from financing was up +88.51% on September 30, 2026

What is 1-year change in ABBV TTM cash from financing?

ABBV TTM cash from financing is up +90.39% year-over-year

How far is ABBV TTM cash from financing from its all-time high?

ABBV TTM cash from financing is currently -106.83% below its historical high of $21.67B set on March 31, 2020

How does ABBV TTM cash from financing rank versus sector peers?

ABBV TTM cash from financing is higher than 3.04% of companies in Healthcare sector

When is ABBV next earnings release?

The next earnings release for ABBV is on February 3, 2027

AbbVie Inc. (ABBV) CFF History & Chart Since 2009

Annual CFF

-$12.72B$7.51B-144.18%

December 31, 2025

Summary

Current Value: As of today, ABBV annual cash from financing is -$12.72B, down -144.18% on December 31, 2025
Historical Performance: ABBV annual cash from financing is up +48.70% over the past 3 years, down -10.63% over the past 5 years
All-Time High Comparison: ABBV annual cash from financing is currently -168.01% below its historical high of $18.71B set on December 31, 2019
3-Year Low Comparison: ABBV annual cash from financing is +48.70% above its 3-year low of -$24.80B reached on an earlier date
Sector Comparison: ABBV annual cash from financing is higher than 0.18% of companies in Healthcare sector

Cash From Financing Chart

beforeafter

Performance

ABBV Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash From Financing	Dec 31, 25	-$12.72B	-144.2%	+48.7%	-10.6%	-10000.0%
Quarterly Cash From Financing	Sep 30, 26	$6.82B	+248.6%	+356.3%	+287.2%	+402.9%
TTM Cash From Financing	Sep 30, 26	-$1.48B	+90.4%	+93.4%	+91.0%	+71.6%
Price	Nov 13, 26	$295.03	+27.0%	+112.8%	+152.2%	–
Annual Cash From Operations	Dec 31, 25	$19.03B	+1.2%	-23.7%	+8.2%	+282.4%
Annual Cash From Investing	Dec 31, 25	-$6.64B	+68.1%	-966.3%	+82.3%	-110.1%
Annual Dividends Paid	Dec 31, 25	$11.66B	+5.7%	+16.1%	+51.1%	+100.0%
Annual Total Debt	Dec 31, 25	$68.38B	+0.8%	+6.5%	-21.5%	+100.0%
Shares Outstanding	Nov 6, 26	1.77B	+0.0%	+0.1%	-0.0%	–

Cash From Financing Highs

ABBV Annual Cash From Financing Highs Comparison
Period	High	Date	Current
3Y	-$5.21B	Dec 31, 24	-144.2%
5Y	-$5.21B	Dec 31, 24	-144.2%
All	$18.71B	Dec 31, 19	-168.0%

Cash From Financing Lows

ABBV Annual Cash From Financing Lows Comparison
Period	Low	Date	Current
3Y	-$24.80B	N/A	+48.7%
5Y	-$24.80B	Dec 31, 22	+48.7%
All	-$24.80B	Dec 31, 22	+48.7%

Cash From Financing History

Year	Value	Change
2025	-$12.72B	-144.2%
2024	-$5.21B	+69.7%
2023	-$17.18B	+30.7%
2022	-$24.80B	-30.3%
2021	-$19.04B	-65.5%
2020	-$11.50B	-161.5%
2019	$18.71B	+230.0%
2018	-$14.40B	-161.2%
2017	-$5.51B	-40.3%

Year	Value	Change
2016	-$3.93B	-168.3%
2015	$5.75B	+274.7%
2014	-$3.29B	+4.3%
2013	-$3.44B	-278.2%
2012	$1.93B	+128.5%
2011	-$6.78B	>-9,900.0%
2010	$65.21M	+101.3%
2009	-$4.88B	-

FAQ

What is the current annual cash from financing of ABBV?: As of today, ABBV annual cash from financing is -$12.72B
What is 1-year change in ABBV annual cash from financing?: ABBV annual cash from financing is down -144.18% year-over-year
What is 3-year change in ABBV annual cash from financing?: ABBV annual cash from financing is up +48.70% over the past 3 years
How far is ABBV annual cash from financing from its all-time high?: ABBV annual cash from financing is currently -168.01% below its historical high of $18.71B set on December 31, 2019
How does ABBV annual cash from financing rank versus sector peers?: ABBV annual cash from financing is higher than 0.18% of companies in Healthcare sector
When is ABBV next annual earnings release?: The next annual earnings release for ABBV is on February 3, 2027

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Quarterly CFF

$6.82B$11.87B+234.94%

September 30, 2026

Summary

Current Value: As of today, ABBV quarterly cash from financing is $6.82B, up +234.94% on September 30, 2026
Historical Performance: ABBV quarterly cash from financing is up +248.58% year-over-year, up +356.29% over the past 3 years
All-Time High Comparison: ABBV quarterly cash from financing is currently -74.36% below its historical high of $26.60B set on December 31, 2019
3-Year Low Comparison: ABBV quarterly cash from financing is +199.40% above its 3-year low of -$6.86B reached on December 31, 2024
Sector Comparison: ABBV quarterly cash from financing is higher than 100.00% of companies in Healthcare sector

Performance

ABBV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash From Financing	Sep 30, 26	$6.82B	+234.9%	+248.6%	+356.3%	+287.2%
Annual Cash From Financing	Dec 31, 25	-$12.72B	–	-144.2%	+48.7%	-10.6%
TTM Cash From Financing	Sep 30, 26	-$1.48B	+88.5%	+90.4%	+93.4%	+91.0%
Price	Nov 13, 26	$295.03	+17.6%	+27.0%	+112.8%	+152.2%
Quarterly Cash From Operations	Sep 30, 26	$7.61B	+121.4%	+8.3%	+0.4%	-4.2%
Quarterly Cash From Investing	Sep 30, 26	-$10.22B	-753.4%	-213.0%	-2668.3%	-1561.0%
Quarterly Dividends Paid	Sep 30, 26	$3.07B	+0.0%	+5.5%	+16.9%	+32.7%
Quarterly Total Debt	Sep 30, 26	$80.90B	+14.2%	+17.7%	+33.2%	+0.2%
Shares Outstanding	Nov 6, 26	1.77B	–	+0.0%	+0.1%	-0.0%

Quarterly Cash From Financing Highs

ABBV Quarterly Cash From Financing Highs Comparison
Period	High	Date	Current
1Y	$6.82B	Sep 30, 26	at high
3Y	$10.82B	Mar 31, 24	-37.0%
5Y	$10.82B	Mar 31, 24	-37.0%
All	$26.60B	Dec 31, 19	-74.4%

Quarterly Cash From Financing Lows

ABBV Quarterly Cash From Financing Lows Comparison
Period	Low	Date	Current
1Y	-$5.05B	Jun 30, 26	+234.9%
3Y	-$6.86B	Dec 31, 24	+199.4%
5Y	-$9.63B	Dec 31, 22	+170.8%
All	-$9.63B	Dec 31, 22	+170.8%

Quarterly Cash From Financing History

Month	Value	Change
Sep 2026	$6.82B	+234.9%
Jun 2026	-$5.05B	-649.9%
Mar 2026	$919.00M	+122.1%
Dec 2025	-$4.17B	+9.2%
Sep 2025	-$4.59B	-69.4%
Jun 2025	-$2.71B	-115.4%
Mar 2025	-$1.26B	+81.7%
Dec 2024	-$6.86B	-123.3%
Sep 2024	-$3.07B	+49.6%
Jun 2024	-$6.10B	-156.4%
Mar 2024	$10.82B	+345.3%
Dec 2023	-$4.41B	-65.8%
Sep 2023	-$2.66B	+32.1%
Jun 2023	-$3.92B	+36.7%
Mar 2023	-$6.19B	+35.7%
Dec 2022	-$9.63B	-74.6%
Sep 2022	-$5.52B	-106.0%
Jun 2022	-$2.68B	+61.6%
Mar 2022	-$6.97B	-10.0%
Dec 2021	-$6.34B	-74.0%
Sep 2021	-$3.64B	+38.1%
Jun 2021	-$5.88B	-85.4%
Mar 2021	-$3.17B	+14.1%
Dec 2020	-$3.70B	-31.3%
Sep 2020	-$2.81B	-9.5%
Jun 2020	-$2.57B	-6.1%
Mar 2020	-$2.42B	-109.1%
Dec 2019	$26.60B	+4,446.7%
Sep 2019	-$612.00M	+67.8%
Jun 2019	-$1.90B	+64.7%
Mar 2019	-$5.38B	-40.7%
Dec 2018	-$3.83B	-517.6%

Month	Value	Change
Sep 2018	$916.00M	+110.2%
Jun 2018	-$8.98B	-257.8%
Mar 2018	-$2.51B	-30.1%
Dec 2017	-$1.93B	-138.0%
Sep 2017	-$810.00M	+17.3%
Jun 2017	-$980.00M	+45.4%
Mar 2017	-$1.79B	+28.3%
Dec 2016	-$2.50B	-82.5%
Sep 2016	-$1.37B	-217.8%
Jun 2016	$1.16B	+195.5%
Mar 2016	-$1.22B	+49.9%
Dec 2015	-$2.43B	-130.2%
Sep 2015	-$1.06B	-110.4%
Jun 2015	$10.17B	+1,193.4%
Mar 2015	-$930.00M	-5.4%
Dec 2014	-$882.00M	-22.7%
Sep 2014	-$719.00M	-73.3%
Jun 2014	-$415.00M	+67.5%
Mar 2014	-$1.28B	-71.0%
Dec 2013	-$747.00M	-21.9%
Sep 2013	-$613.00M	-22.6%
Jun 2013	-$500.00M	+68.4%
Mar 2013	-$1.58B	-166.2%
Dec 2012	$2.39B	+6.4%
Sep 2012	$2.24B	+269.2%
Jun 2012	-$1.33B	+3.6%
Mar 2012	-$1.38B	+11.9%
Dec 2011	-$1.56B	+30.7%
Sep 2011	-$2.25B	-26.9%
Jun 2011	-$1.77B	-48.3%
Mar 2011	-$1.20B	-

FAQ

What is the current quarterly cash from financing of ABBV?: As of today, ABBV quarterly cash from financing is $6.82B
What is ABBV quarterly cash from financing most recent change?: ABBV quarterly cash from financing was up +234.94% on September 30, 2026
What is 1-year change in ABBV quarterly cash from financing?: ABBV quarterly cash from financing is up +248.58% year-over-year
How far is ABBV quarterly cash from financing from its all-time high?: ABBV quarterly cash from financing is currently -74.36% below its historical high of $26.60B set on December 31, 2019
How does ABBV quarterly cash from financing rank versus sector peers?: ABBV quarterly cash from financing is higher than 100.00% of companies in Healthcare sector
When is ABBV next earnings release?: The next earnings release for ABBV is on February 3, 2027

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TTM CFF

-$1.48B$11.41B+88.51%

September 30, 2026

Summary

Current Value: As of today, ABBV TTM cash from financing is -$1.48B, up +88.51% on September 30, 2026
Historical Performance: ABBV TTM cash from financing is up +90.39% year-over-year, up +93.39% over the past 3 years
All-Time High Comparison: ABBV TTM cash from financing is currently -106.83% below its historical high of $21.67B set on March 31, 2020
3-Year Low Comparison: ABBV TTM cash from financing is +93.39% above its 3-year low of -$22.41B reached on an earlier date
Sector Comparison: ABBV TTM cash from financing is higher than 3.04% of companies in Healthcare sector

Performance

ABBV Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM Cash From Financing	Sep 30, 26	-$1.48B	+88.5%	+90.4%	+93.4%	+91.0%
Annual Cash From Financing	Dec 31, 25	-$12.72B	–	-144.2%	+48.7%	-10.6%
Quarterly Cash From Financing	Sep 30, 26	$6.82B	+234.9%	+248.6%	+356.3%	+287.2%
Price	Nov 13, 26	$295.03	+17.6%	+27.0%	+112.8%	+152.2%
TTM Cash From Operations	Sep 30, 26	$20.09B	+3.0%	-3.7%	-21.3%	-10.9%
TTM Cash From Investing	Sep 30, 26	-$13.45B	-107.0%	-90.7%	-711.6%	-636.5%
TTM Dividends Paid	Sep 30, 26	$12.14B	+1.3%	+5.6%	+16.5%	+34.1%
Quarterly Total Debt	Sep 30, 26	$80.90B	+14.2%	+17.7%	+33.2%	+0.2%
Shares Outstanding	Nov 6, 26	1.77B	–	+0.0%	+0.1%	-0.0%

TTM Cash From Financing Highs

ABBV TTM Cash From Financing Highs Comparison
Period	High	Date	Current
1Y	-$1.48B	Sep 30, 26	at high
3Y	-$173.00M	Mar 31, 24	-756.1%
5Y	-$173.00M	Mar 31, 24	-756.1%
All	$21.67B	Mar 31, 20	-106.8%

TTM Cash From Financing Lows

ABBV TTM Cash From Financing Lows Comparison
Period	Low	Date	Current
1Y	-$15.42B	N/A	+90.4%
3Y	-$22.41B	N/A	+93.4%
5Y	-$25.26B	Jun 30, 23	+94.1%
All	-$25.26B	Jun 30, 23	+94.1%

TTM Cash From Financing History

Month	Value	Change
Sep 2026	-$1.48B	+88.5%
Jun 2026	-$12.89B	-22.2%
Mar 2026	-$10.55B	+17.1%
Dec 2025	-$12.72B	+17.5%
Sep 2025	-$15.42B	-10.9%
Jun 2025	-$13.90B	+19.6%
Mar 2025	-$17.29B	-231.8%
Dec 2024	-$5.21B	-88.7%
Sep 2024	-$2.76B	-17.5%
Jun 2024	-$2.35B	-1,258.4%
Mar 2024	-$173.00M	+99.0%
Dec 2023	-$17.18B	+23.3%
Sep 2023	-$22.41B	+11.3%
Jun 2023	-$25.26B	-5.2%
Mar 2023	-$24.02B	+3.1%
Dec 2022	-$24.80B	-15.3%
Sep 2022	-$21.51B	-9.6%
Jun 2022	-$19.63B	+14.0%
Mar 2022	-$22.84B	-19.9%
Dec 2021	-$19.04B	-16.1%
Sep 2021	-$16.40B	-5.3%
Jun 2021	-$15.57B	-27.0%
Mar 2021	-$12.25B	-6.5%
Dec 2020	-$11.50B	-161.2%
Sep 2020	$18.80B	-10.5%
Jun 2020	$21.00B	-3.1%
Mar 2020	$21.67B	+15.8%
Dec 2019	$18.71B	+259.6%
Sep 2019	-$11.72B	-15.0%
Jun 2019	-$10.19B	+41.0%
Mar 2019	-$17.27B	-20.0%
Dec 2018	-$14.40B	-15.2%

Month	Value	Change
Sep 2018	-$12.50B	+12.1%
Jun 2018	-$14.23B	-128.4%
Mar 2018	-$6.23B	-13.0%
Dec 2017	-$5.51B	+9.4%
Sep 2017	-$6.09B	+8.4%
Jun 2017	-$6.65B	-47.6%
Mar 2017	-$4.50B	-14.6%
Dec 2016	-$3.93B	-1.8%
Sep 2016	-$3.86B	-8.9%
Jun 2016	-$3.54B	-164.8%
Mar 2016	$5.46B	-5.0%
Dec 2015	$5.75B	-21.2%
Sep 2015	$7.30B	-4.4%
Jun 2015	$7.64B	+359.3%
Mar 2015	-$2.95B	+10.5%
Dec 2014	-$3.29B	-4.3%
Sep 2014	-$3.16B	-3.5%
Jun 2014	-$3.05B	+2.7%
Mar 2014	-$3.14B	+8.9%
Dec 2013	-$3.44B	-1,023.8%
Sep 2013	-$306.29M	-112.0%
Jun 2013	$2.55B	+47.9%
Mar 2013	$1.73B	-10.7%
Dec 2012	$1.93B	+195.7%
Sep 2012	-$2.02B	+69.0%
Jun 2012	-$6.51B	+6.4%
Mar 2012	-$6.96B	-2.6%
Dec 2011	-$6.78B	-29.9%
Sep 2011	-$5.22B	-75.8%
Jun 2011	-$2.97B	-148.3%
Mar 2011	-$1.20B	-

FAQ

What is the current TTM cash from financing of ABBV?: As of today, ABBV TTM cash from financing is -$1.48B
What is ABBV TTM cash from financing most recent change?: ABBV TTM cash from financing was up +88.51% on September 30, 2026
What is 1-year change in ABBV TTM cash from financing?: ABBV TTM cash from financing is up +90.39% year-over-year
How far is ABBV TTM cash from financing from its all-time high?: ABBV TTM cash from financing is currently -106.83% below its historical high of $21.67B set on March 31, 2020
How does ABBV TTM cash from financing rank versus sector peers?: ABBV TTM cash from financing is higher than 3.04% of companies in Healthcare sector
When is ABBV next earnings release?: The next earnings release for ABBV is on February 3, 2027

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

ABBV Official Website www.abbvie.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm
ABBV Profile on Yahoo Finance finance.yahoo.com/quote/ABBV
ABBV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abbv